Creative Planning
RYTM icon

Creative Planning’s Rhythm Pharmaceuticals RYTM Stock Holding History

Creative Planning’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Buy
25,835
+4,750
+23% +$429K ﹤0.01% 1815
2026
Q1 		$1.83M Sell
21,085
-4,121
-16% -$401K ﹤0.01% 1964
2025
Q4 		$2.7M Buy
25,206
+261
+1% +$27.7K ﹤0.01% 1464
2025
Q3 		$2.52M Buy
24,945
+7,723
+45% +$717K ﹤0.01% 1354
2025
Q2 		$1.09M Buy
17,222
+4,889
+40% +$299K ﹤0.01% 1784
2025
Q1 		$653K Buy
12,333
+2,109
+21% +$117K ﹤0.01% 2063
2024
Q4 		$572K Buy
10,224
+1,630
+19% +$90K ﹤0.01% 2103
2024
Q3 		$450K Buy
+8,594
New +$412K ﹤0.01% 2199

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Creative Planning's RYTM Position: Q2 2026 in Review

Creative Planning increased its Rhythm Pharmaceuticals (RYTM) stake by 23% in Q2 2026, buying an estimated $429K and bringing the position to 25,835 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Creative Planning first reported a position in RYTM in Q3 2024 and has held it in 8 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Creative Planning held 25,835 shares of Rhythm Pharmaceuticals worth $2.87M as of Q2 2026.
  • Creative Planning bought 4,750 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $429K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1815 holding.
  • Creative Planning first reported a position in Rhythm Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.